These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4466884)

  • 1. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of anabolic steroids in postinfarct cardiosclerosis].
    Baturina TS; Bondarenko IP; Vlasenko LI; Dubinskiĭ AA; Meĭtin IIa
    Vrach Delo; 1982 Apr; (4):49-52. PubMed ID: 7101857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nerobol on the contractile capacity of the myocardium].
    Beĭ PI
    Klin Med (Mosk); 1972 Jan; 50(1):69-74. PubMed ID: 5020033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of anabolic steroid preparations on blood coagulation processes].
    Karacharov AT
    Klin Med (Mosk); 1971 Oct; 49(10):131-4. PubMed ID: 5133136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of milurite in ischemic heart disease].
    Teslenko VG; Khimenko LP
    Vrach Delo; 1980 Oct; (10):18-21. PubMed ID: 7434694
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anabolic steroids and the functional state of the liver].
    Volkov NF; Galkin LP; Petlitskiĭ SI; Stolpinskiĭ AA
    Ter Arkh; 1972 Dec; 44(12):71-5. PubMed ID: 4666355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of nerobol in combination with potassium salts in patients with chronic coronary insufficiency].
    Leshchinskiĭ LA; Kharitonova VV
    Klin Med (Mosk); 1970 Oct; 48(10):38-42. PubMed ID: 5505243
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles in the use of drugs in neurogeriatrics].
    Mankovsky NB; Mintse AY; Vainchtock AB
    G Gerontol; 1972 Mar; 20(3):246-55. PubMed ID: 5030361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience in the therapeutic use of methylandrostenediole in patients with myocardial dystrophy and atherosclerotic cardiosclerosis].
    Leshchinskiĭ LA; Pevchikh VV; Petrov NM
    Ter Arkh; 1967 Sep; 39(9):84-7. PubMed ID: 5611709
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.